Phosphate Sensing

Advances in Chronic Kidney Disease

Volumn 18, Issue 2, 2011, Pages 132-144

  Bergwitz, Clemens ^a   Jüppner, Harald ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bacterial phosphate sensor; Human phosphate homeostasis; Metazoan phosphate sensor; Yeast phosphate sensor

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; FIBROBLAST GROWTH FACTOR 23; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATE;

BACTERIUM; ENDOCRINE SYSTEM; ENZYME ACTIVATION; HUMAN; INTRACELLULAR SIGNALING; METABOLISM; NONHUMAN; PARATHYROID HORMONE RELEASE; PHOSPHATE METABOLISM; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SENSOR; YEAST;

BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; BIOLOGICAL TRANSPORT, ACTIVE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; MICROBIOLOGICAL PROCESSES; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATES; SIGNAL TRANSDUCTION; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS; YEASTS;

EID: 79952590847     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2011.01.004     Document Type: Review

References (166)

1. Bevington A., Kemp G.J., Graham R., Russell G. Phosphate-sensitive enzymes: possible molecular basis for cellular disorders of phosphate metabolism. Clin Chem Enzyme Commun 1992, 4:235-257.
2. Bevington A., Mundy K.I., Yates A.J., et al. A study of intracellular orthophosphate concentration in human muscle and erythrocytes by 31P nuclear magnetic resonance spectroscopy and selective chemical assay. Clin Sci (Lond) 1986, 71:729-735.
3. Gaddum J.H. The estimation of phosphorus in blood. Biochem J 1926, 20:1204-1207.
4. Bun-Ya M., Nishimura M., Harashima S., Oshima Y. The PHO84 gene of Saccharomyces cerevisiae encodes an inorganic phosphate transporter. Mol Cell Biol 1991, 11:3229-3238.
5. Murer H., Forster I., Biber J. The sodium phosphate cotransporter family SLC34. Pflugers Arch 2004, 447:763-767.
6. Wohlrab H. Molecular aspects of inorganic phosphate transport in mitochondria. Biochim Biophys Acta 1986, 853:115-134.
7. Ferreira G.C., Pedersen P.L. Phosphate transport in mitochondria: past accomplishments, present problems, and future challenges. J Bioenerg Biomembr 1993, 25:483-492.
8. Pisoni R.L., Lindley E.R. Incorporation of [32P]orthophosphate into long chains of inorganic polyphosphate within lysosomes of human fibroblasts. J Biol Chem 1992, 267:3626-3631.
9. Pisoni R.L. Characterization of a phosphate transport system in human fibroblast lysosomes. J Biol Chem 1991, 266:979-985.
10. Burchell A. Endoplasmic reticulum phosphate transport. Kidney Int 1996, 49:953-958.
11. Bringhurst F.R., Leder B.Z. Regulation of calcium and phosphate homeostasis. Endocrinology 2006, 805-843. WB Saunders Co, Philadelphia, PA. 5th ed. L.J. DeGroot, J.L. Jameson (Eds.).
12. Razzaque M.S. Does FGF23 toxicity influence the outcome of chronic kidney disease?. Nephrol Dial Transplant 2009, 24:4-7.
13. Gutierrez O.M., Mannstadt M., Isakova T., et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008, 359:584-592.
14. Mizobuchi M., Towler D., Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 2009, 20:1453-1464.
15. Stubbs J.R., Liu S., Tang W., et al. Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 2007, 18:2116-2124.
16. Morishita K., Shirai A., Kubota M., et al. The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc. J Nutr 2001, 131:3182-3188.
17. Thevelein J.M., Gelade R., Holsbeeks I., et al. Nutrient sensing systems for rapid activation of the protein kinase A pathway in yeast. Biochem Soc Trans 2005, 33:253-256.
18. 2+-sensing receptor from bovine parathyroid. Nature 1993, 366:575-580.
19. Brown E.J., Albers M.W., Shin T.B., et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 1994, 369:756-758.
20. MacDonald P.E., Joseph J.W., Rorsman P. Glucose-sensing mechanisms in pancreatic beta-cells. Philos Trans R Soc Lond B Biol Sci 2005, 360:2211-2225.
21. Hsieh Y.J., Wanner B.L. Global regulation by the seven-component Pi signaling system. Curr Opin Microbiol 2010, 13:198-203.
22. Lamarche M.G., Wanner B.L., Crepin S., Harel J. The phosphate regulon and bacterial virulence: a regulatory network connecting phosphate homeostasis and pathogenesis. FEMS Microbiol Rev 2008, 32:461-473.
23. Zundel C.J., Capener D.C., McCleary W.R. Analysis of the conserved acidic residues in the regulatory domain of PhoB. FEBS Lett 1998, 441:242-246.
24. VanBogelen R.A., Olson E.R., Wanner B.L., Neidhardt F.C. Global analysis of proteins synthesized during phosphorus restriction in Escherichia coli. J Bacteriol 1996, 178:4344-4366.
25. Yuan Z.C., Zaheer R., Morton R., Finan T.M. Genome prediction of PhoB regulated promoters in Sinorhizobium meliloti and twelve proteobacteria. Nucleic Acids Res 2006, 34:2686-2697.
26. Beard S.J., Hashim R., Wu G., Binet M.R., Hughes M.N., Poole R.K. Evidence for the transport of zinc(II) ions via the pit inorganic phosphate transport system in Escherichia coli. FEMS Microbiol Lett 2000, 184:231-235.
27. Morales R., Berna A., Carpentier P., et al. Serendipitous discovery and X-ray structure of a human phosphate binding apolipoprotein. Structure 2006, 14:601-609.
28. Berna A., Scott K., Chabriere E., Bernier F. The DING family of proteins: ubiquitous in eukaryotes, but where are the genes?. Bioessays 2009, 31:570-580.
29. Mouillon J.M., Persson B.L. New aspects on phosphate sensing and signalling in Saccharomyces cerevisiae. FEMS Yeast Res 2006, 6:171-176.
30. Persson B.L., Lagerstedt J.O., Pratt J.R., et al. Regulation of phosphate acquisition in Saccharomyces cerevisiae. Curr Genet 2003, 43:225-244.
31. Toh-e A., Tanaka K., Uesono Y., Wickner R.B. PHO85, a negative regulator of the PHO system, is a homolog of the protein kinase gene, CDC28, of Saccharomyces cerevisiae. Mol Gen Genet 1988, 214:162-164.
32. Oshima Y. The phosphatase system in Saccharomyces cerevisiae. Genes Genet Syst 1997, 72:323-334.
33. Kaffman A., Herskowitz I., Tjian R., O'Shea E.K. Phosphorylation of the transcription factor PHO4 by a cyclin-CDK complex, PHO80-PHO85. Science 1994, 263:1153-1156.
34. Lenburg M.E., O'Shea E.K. Signaling phosphate starvation. Trends Biochem Sci 1996, 21:383-387.
35. Fristedt U., Berhe A., Ensler K., Norling B., Persson B.L. Isolation and characterization of membrane vesicles of Saccharomyces cerevisiae harboring the high-affinity phosphate transporter. Arch Biochem Biophys 1996, 330:133-141.
36. Auesukaree C., Homma T., Tochio H., Shirakawa M., Kaneko Y., Harashima S. Intracellular phosphate serves as a signal for the regulation of the PHO pathway in Saccharomyces cerevisiae. J Biol Chem 2004, 279:17289-17294.
37. Lagerstedt J.O., Voss J.C., Wieslander A., Persson B.L. Structural modeling of dual-affinity purified Pho84 phosphate transporter. FEBS Lett 2004, 578:262-268.
38. Pratt J.R., Mouillon J.M., Lagerstedt J.O., Pattison-Granberg J., Lundh K.I., Persson B.L. Effects of methylphosphonate, a phosphate analogue, on the expression and degradation of the high-affinity phosphate transporter Pho84, in Saccharomyces cerevisiae. Biochemistry 2004, 43:14444-14453.
39. Mouillon J.M., Persson B.L. Inhibition of the protein kinase A alters the degradation of the high-affinity phosphate transporter Pho84 in Saccharomyces cerevisiae. Curr Genet 2005, 48:226-234.
40. Huang K., Ferrin-O'Connell I., Zhang W., Leonard G.A., O'Shea E.K., Quiocho F.A. Structure of the Pho85-Pho80 CDK-cyclin complex of the phosphate-responsive signal transduction pathway. Mol Cell 2007, 28:614-623.
41. Huang S., Jeffery D.A., Anthony M.D., O'Shea E.K. Functional analysis of the cyclin-dependent kinase inhibitor Pho81 identifies a novel inhibitory domain. Mol Cell Biol 2001, 21:6695-6705.
42. Lee Y.S., Mulugu S., York J.D., O'Shea E.K. Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates. Science 2007, 316:109-112.
43. Lee Y.S., Huang K., Quiocho F.A., O'Shea E.K. Molecular basis of cyclin-CDK-CKI regulation by reversible binding of an inositol pyrophosphate. Nat Chem Biol 2008, 4:25-32.
44. Swinnen E., Rosseels J., Winderickx J. The minimum domain of Pho81 is not sufficient to control the Pho85-Rim15 effector branch involved in phosphate starvation-induced stress responses. Curr Genet 2005, 48:18-33.
45. Swinnen E., Wanke V., Roosen J., et al. Rim15 and the crossroads of nutrient signalling pathways in Saccharomyces cerevisiae. Cell Div 2006, 1:3.
46. Petersson J., Pattison J., Kruckeberg A.L., Berden J.A., Persson B.L. Intracellular localization of an active green fluorescent protein-tagged Pho84 phosphate permease in Saccharomyces cerevisiae. FEBS Lett 1999, 462:37-42.
47. Werner A., Kinne R.K. Evolution of the Na-P(i) cotransport systems. Am J Physiol Regul Integr Comp Physiol 2001, 280:R301-R312.
48. Hubbard T.J., Aken B.L., Beal K., et al. Ensembl 2007. Nucleic Acids Res 2007, 35:D610-D617.
49. Kido S., Miyamoto K., Mizobuchi H., et al. Identification of regulatory sequences and binding proteins in the type II sodium/phosphate cotransporter NPT2 gene responsive to dietary phosphate. J Biol Chem 1999, 274:28256-28263.
50. Kornberg A., Rao N.N., Ault-Riche D. Inorganic polyphosphate: a molecule of many functions. Annu Rev Biochem 1999, 68:89-125.
51. Brown M.R., Kornberg A. Inorganic polyphosphate in the origin and survival of species. Proc Natl Acad Sci USA 2004, 101:16085-16087.
52. Kato J., Yamamoto T., Yamada K., Ohtake H. Cloning, sequence and characterization of the polyphosphate kinase-encoding gene (ppk) of Klebsiella aerogenes. Gene 1993, 137:237-242.
53. Ghorbel S., Kormanec J., Artus A., Virolle M.J. Transcriptional studies and regulatory interactions between the phoR-phoP operon and the phoU, mtpA, and ppk genes of Streptomyces lividans TK24. J Bacteriol 2006, 188:677-686.
54. Rao N.N., Kornberg A. Inorganic polyphosphate regulates responses of Escherichia coli to nutritional stringencies, environmental stresses and survival in the stationary phase. Prog Mol Subcell Biol 1999, 23:183-195.
55. The Biochemistry of Inorganic Polyphosphates 1979, Wiley, New York, NY. I. Kulaev (Ed.).
56. Kulaev I.S., Vagabov V.M. Polyphosphate metabolism in micro-organisms. Adv Microb Physiol 1983, 24:83-171.
57. Kulaev I., Kulakovskaya T. Polyphosphate and phosphate pump. Annu Rev Microbiol 2000, 54:709-734.
58. Kulaev I., Vagabov V., Kulakovskaya T. New aspects of inorganic polyphosphate metabolism and function. J Biosci Bioeng 1999, 88:111-129.
59. Thomas M.R., O'Shea E.K. An intracellular phosphate buffer filters transient fluctuations in extracellular phosphate levels. Proc Natl Acad Sci USA 2005, 102:9565-9570.
60. Docampo R., de Souza W., Miranda K., Rohloff P., Moreno S.N. Acidocalcisomes - conserved from bacteria to man. Nat Rev Microbiol 2005, 3:251-261.
61. Kumble K.D., Kornberg A. Inorganic polyphosphate in mammalian cells and tissues. J Biol Chem 1995, 270:5818-5822.
62. Schmelzle T., Hall M.N. TOR, a central controller of cell growth. Cell 2000, 103:253-262.
63. Tang H., Hornstein E., Stolovich M., et al. Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol Cell Biol 2001, 21:8671-8683.
64. Jacinto E., Hall M.N. TOR signalling in bugs, brain and brawn. Nat Rev Mol Cell Biol 2003, 4:117-126.
65. Martin K.A., Blenis J. Coordinate regulation of translation by the PI 3-kinase and mTOR pathways. Adv Cancer Res 2002, 86:1-39.
66. Shiba T., Nishimura D., Kawazoe Y., et al. Modulation of mitogenic activity of fibroblast growth factors by inorganic polyphosphate. J Biol Chem 2003, 278:26788-26792.
67. Hernandez-Ruiz L., Gonzalez-Garcia I., Castro C., Brieva J.A., Ruiz F.A. Inorganic polyphosphate and specific induction of apoptosis in human plasma cells. Haematologica 2006, 91:1180-1186.
68. Beck G.R. Inorganic phosphate as a signaling molecule in osteoblast differentiation. J Cell Biochem 2003, 90:234-243.
69. Schoeters G.E., de Saint-Georges L., Van den Heuvel R., Vanderborght O. Mineralization of adult mouse bone marrow in vitro. Cell Tissue Kinet 1988, 21:363-374.
70. Xie J., Baumann M.J., McCabe L.R. Osteoblasts respond to hydroxyapatite surfaces with immediate changes in gene expression. J Biomed Mater Res A 2004, 71:108-117.
71. Quarles L.D., Yohay D.A., Lever L.W., Caton R., Wenstrup R.J. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 1992, 7:683-692.
72. Otsuka E., Yamaguchi A., Hirose S., Hagiwara H. Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. Am J Physiol 1999, 277:C132-C138.
73. Berendsen A.D., Smit T.H., Schoenmaker T., et al. Inorganic phosphate stimulates DMP1 expression in human periodontal ligament fibroblasts embedded in three-dimensional collagen gels. Cells Tissues Organs 2010, 192:116-124.
74. Beck G.R., Sullivan E.C., Moran E., Zerler B. Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3-E1 osteoblasts. J Cell Biochem 1998, 68:269-280.
75. Beck G.R., Zerler B., Moran E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci USA 2000, 97:8352-8357.
76. Yoshiko Y., Candeliere G.A., Maeda N., Aubin J.E. Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization. Mol Cell Biol 2007, 27:4465-4474.
77. Chang S.H., Yu K.N., Lee Y.S., et al. Elevated inorganic phosphate stimulates Akt-ERK1/2-Mnk1 signaling in human lung cells. Am J Respir Cell Mol Biol 2006, 35:528-539.
78. Goseki-Sone M., Yamada A., Hamatani R., Mizoi L., Iimura T., Ezawa I. Phosphate depletion enhances bone morphogenetic protein-4 gene expression in a cultured mouse marrow stromal cell line ST2. Biochem Biophys Res Commun 2002, 299:395-399.
79. Kimata M., Michigami T., Tachikawa K., et al. Signaling of extracellular inorganic phosphate up-regulates cyclin D1 expression in proliferating chondrocytes via the Na(+)/Pi cotransporter Pit-1 and Raf/MEK/ERK pathway. Bone 2010, 47:938-947.
80. Beck G.R., Knecht N. Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent. J Biol Chem 2003, 278:41921-41929.
81. Julien M., Magne D., Masson M., et al. Phosphate stimulates matrix Gla protein expression in chondrocytes through the extracellular signal regulated kinase signaling pathway. Endocrinology 2007, 148:530-537.
82. Nair D., Misra R.P., Sallis J.D., Cheung H.S. Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway. J Biol Chem 1997, 272:18920-18925.
83. Yamazaki M., Ozonoa K., Okada T., et al. Both FGF23 and extracellular phosphate activate Raf/MEK/ERK pathway via FGF receptors in HEK293 cells. J Cell Biochem 2010, 111:1210-1221.
84. Bergwitz C, DeRobertis C, Chen H, Friedman A, Jüppner H, Perrimon N. Role of sodium-phosphate co-transporters in the activation of the MAPK pathway by phosphate. J Am Soc Nephrol. In press. Abstract F-FC258.
85. Mansfield K., Teixeira C.C., Adams C.S., Shapiro I.M. Phosphate ions mediate chondrocyte apoptosis through a plasma membrane transporter mechanism. Bone 2001, 28:1-8.
86. Beck L., Leroy C., Salaun C., Margall-Ducos G., Desdouets C., Friedlander G. Identification of a novel function of PiT1 critical for cell proliferation and independent of its phosphate transport activity. J Biol Chem 2009, 284:31363-31374.
87. Suzuki A., Ammann P., Nishiwaki-Yasuda K., Sekiguchi S., Asano S., Nagao S., et al. Effects of transgenic Pit-1 overexpression on calcium phosphate and bone metabolism. J Bone Miner Metab 2010 Mar, 28(2):139-148.
88. Beck L., Leroy C., Beck-Cormier S., Forand A., Salaun C., Paris N., et al. The phosphate transporter PiT1 (Slc20a1) revealed as a new essential gene for mouse liver development. PLoS One 2010, 5:e9148.
89. Julien M., Khoshniat S., Lacreusette A., et al. Phosphate-dependent regulation of MGP in osteoblasts: role of ERK1/2 and Fra-1. J Bone Miner Res 2009, 24:1856-1868.
90. Meng Z., Camalier C.E., Lucas D.A., Veenstra T.D., Beck G.R., Conrads T.P. Probing early growth response 1 interacting proteins at the active promoter in osteoblast cells using oligoprecipitation and mass spectrometry. J Proteome Res 2006, 5:1931-1939.
91. Beck G.R., Moran E., Knecht N. Inorganic phosphate regulates multiple genes during osteoblast differentiation, including Nrf2. Exp Cell Res 2003, 288:288-300.
92. Conrads K.A., Yu L.R., Lucas D.A., et al. Quantitative proteomic analysis of inorganic phosphate-induced murine MC3T3-E1 osteoblast cells. Electrophoresis 2004, 25:1342-1352.
93. Sabbagh Y., Carpenter T.O., Demay M.B. Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc Natl Acad Sci USA 2005, 102:9637-9642.
94. Miedlich S.U., Zalutskaya A., Zhu E.D., Demay M.B. Phosphate-induced apoptosis of hypertrophic chondrocytes is associated with a decrease in mitochondrial membrane potential and is dependent upon Erk1/2 phosphorylation. J Biol Chem 2010, 285:18270-18275.
95. Oshima Y., Akiyama T., Hikita A., et al. Pivotal role of Bcl-2 family proteins in the regulation of chondrocyte apoptosis. J Biol Chem 2008, 283:26499-26508.
96. Magne D., Bluteau G., Faucheux C., et al. Phosphate is a specific signal for ATDC5 chondrocyte maturation and apoptosis-associated mineralization: possible implication of apoptosis in the regulation of endochondral ossification. J Bone Miner Res 2003, 18:1430-1442.
97. Donohue M.M., Demay M.B. Rickets in VDR null mice is secondary to decreased apoptosis of hypertrophic chondrocytes. Endocrinology 2002, 143:3691-3694.
98. Jüppner H., Gardella T.J., Brown E.M., Kronenberg H.M., Potts J.T. Parathyroid hormone and parathyroid hormone-related peptide in the regulation of calcium homeostasis and bone development. Endocrinology 2006, 1377-1417. Elsevier Saunders, Philadelphia, PA. L.J. DeGroot, J.L. Jameson (Eds.).
99. Potts J.T., Jüppner H. Parathyroid Hormone and parathyroid hormone-related peptide in calcium homeostasis, bone metabolism, and bone development: the proteins, their genes, and receptors. Metabolic Bone Disease 1997, 51-94. Academic Press, New York, NY. L. Avioli, S. Krane (Eds.).
100. White K.E., Larsson T.E., Econs M.J. The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23. Endocr Rev 2006, 27:221-241.
101. Quarles L.D. Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 2008, 118:3820-3828.
102. Bergwitz C., Jüppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 2010, 61:91-104.
103. Urakawa I., Yamazaki Y., Shimada T., et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006, 444:770-774.
104. Miyamoto K.I., Ito M., Tatsumi S., Kuwahata M., Segawa H. New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter. Am J Nephrol 2007, 27:503-515.
105. Forster I.C., Hernando N., Biber J., Murer H. Proximal tubular handling of phosphate: a molecular perspective. Kidney Int 2006, 70:1548-1559.
106. Berndt T., Thomas L.F., Craig T.A., et al. Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sci USA 2007, 104:11085-11090.
107. Stubbs J., Liu S., Quarles L.D. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Semin Dial 2007, 20:302-308.
108. Segawa H., Onitsuka A., Kuwahata M., et al. Type IIc sodium-dependent phosphate transporter regulates calcium metabolism. J Am Soc Nephrol 2009, 20:104-113.
109. Wilz D.R., Gray R.W., Dominguez J.H., Lemann J. Plasma 1,25-(OH)2-vitamin D concentrations and net intestinal calcium, phosphate, and magnesium absorption in humans. Am J Clin Nutr 1979, 32:2052-2060.
110. Nabeshima Y. Discovery of alpha-Klotho unveiled new insights into calcium and phosphate homeostasis. Proc Jpn Acad Ser B Phys Biol Sci 2009, 85:125-141.
111. Strom T.M., Jüppner H. PHEX, FGF23, DMP1 and beyond. Curr Opin Nephrol Hypertens 2008, 17:357-362.
112. Kuro-o M. Endocrine FGFs and Klothos: emerging concepts. Trends Endocrinol Metab 2008, 19:239-245.
113. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009, 94:26-34.
114. Silver J., Levi R. Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease. Kidney Int Suppl 2005, S8-S12.
115. Gardella T.J. Mimetic ligands for the PTHR1: approaches developments, and considerations. IBMS BoneKey 2009, 6:71-85.
116. Kronenberg H.M. PTH regulates the hematopoietic stem cell niche in bone. Adv Exp Med Biol 2007, 602:57-60.
117. Berndt T., Kumar R. Novel mechanisms in the regulation of phosphorus homeostasis. Physiology (Bethesda) 2009, 24:17-25.
118. Kemper B., Habener J.F., Rich A., Potts J.T. Parathyroid secretion: discovery of a major calcium-dependent protein. Science 1974, 184:167-169.
119. Slatopolsky E., Finch J., Denda M., et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996, 97:2534-2540.
120. Sherwood L.M., Mayer G.P., Ramberg C.F., Kronfeld D.S., Aurbach G.D., Potts J.T. Regulation of parathyroid hormone secretion: proportional control by calcium, lack of effect of phosphate. Endocrinology 1968, 83:1043-1051.
121. Almaden Y., Canalejo A., Hernandez A., et al. Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 1996, 970-976.
122. Silver J., Russell J., Sherwood L.M. Regulation by vitamin D metabolites of messenger ribronucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA 1985, 82:4270-4273.
123. Estepa J., Aguilera-Tejero E., Lopez I., Almaden Y., Rodriguez M., Felsenfeld A. Effect of phosphate on parathyroid hormone secretion in vivo. J Bone Miner Res 1999, 14:1848-1854.
124. Moallem E., Kilav R., Silver J., Naveh-Many T. RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J Biol Chem 1998, 273:5253-5259.
125. Naveh-Many T., Rahaminov R., Livini N., Silver J. Parathyroid cell proliferation in normal and chronic renal failure in rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 1995, 96:1786-1793.
126. Galitzer H., Ben-Dov I., Lavi-Moshayoff V., Naveh-Many T., Silver J. Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion. Curr Opin Nephrol Hypertens 2008, 17:363-367.
127. Lavi-Moshayoff V., Silver J., Naveh-Many T. Human PTH gene regulation in vivo using transgenic mice. Am J Physiol Renal Physiol 2009, 297:F713-F719.
128. Ben-Dov I.Z., Galitzer H., Lavi-Moshayoff V., et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest 2007, 117:4003-4008.
129. Krajisnik T., Bjorklund P., Marsell R., et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1 alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 2007, 195:125-131.
130. Imura A., Tsuji Y., Murata M., et al. alpha-Klotho as a regulator of calcium homeostasis. Science 2007, 316:1615-1618.
131. Kilav R., Silver J., Naveh-Many T. Parathyroid hormone gene expression in hypophosphatemic rats. J Clin Invest 1995, 96:327-333.
132. Nechama M., Uchida T., Mor Yosef-Levi I., Silver J., Naveh-Many T. The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism. J Clin Invest 2009, 119:3102-3114.
133. Dinur M., Kilav R., Sela-Brown A., Jacquemin-Sablon H., Naveh-Many T. In vitro evidence that upstream of N-ras participates in the regulation of parathyroid hormone messenger ribonucleic acid stability. Mol Endocrinol 2006, 20:1652-1660.
134. Nechama M., Ben-Dov I.Z., Briata P., Gherzi R., Naveh-Many T. The mRNA decay promoting factor K-homology splicing regulator protein post-transcriptionally determines parathyroid hormone mRNA levels. FASEB J 2008, 22:3458-3468.
135. Bikle D., Adams J., Christakos C., Vitamin D. Production, Metabolism, Mechanism of Action, and Clinical Requirements: primer on Metabolic Bone Disease and Disorders of Mineral Metabolism 2008, Lippincott-Raven, Philadelphia, PA, 141-149.
136. Boullion R. Vitamin D: from photosynthesis, metabolism, and action to clinical application. Endocrinology 2006, 1435-1463. Elsevier Saunders, Philadelphia, PA. L.J. DeGroot, J.L. Jameson (Eds.).
137. Sakaki T., Kagawa N., Yamamoto K., Inouye K. Metabolism of vitamin D3 by cytochromes P450. Front Biosci 2005, 10:119-134.
138. Bai X.Y., Miao D., Goltzman D., Karaplis A.C. The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem 2003, 278:9843-9849.
139. Carpenter T.O., Ellis B.K., Insogna K.L., Philbrick W.M., Sterpka J., Shimkets R. Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J Clin Endocrinol Metab 2005, 90:1012-1020.
140. Berndt T., Craig T., Bowe A., et al. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest 2003, 112:785-794.
141. DeLuca H.F. The metabolism and functions of vitamin D. Adv Exp Med Biol 1986, 196:361-375.
142. Inoue Y., Segawa H., Kaneko I., et al. Role of the vitamin D receptor in FGF23 action on phosphate metabolism. Biochem J 2005, 390:325-331.
143. Yamashita T., Yoshioka M., Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 2000, 277:494-498.
144. Bastepe M., Jüppner H. Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation. Rev Endocr Metab Disord 2008, 9:171-180.
145. von Marschall Z., Fisher L.W. Dentin matrix protein-1 isoforms promote differential cell attachment and migration. J Biol Chem 2008, 283:32730-32740.
146. Yuan B., Meudt J., Feng J.O., Drezner M.K. 7B2 protein mediated inhibition of DMP1 cleavage in osteoblasts enhances FGF-23 production in hyp-mice. J Bone. Miner Res 2008, 23:S16. Abstract 1053.
147. Lu Y., Qin C., Xie Y., Bonewald L.F., Feng J.Q. Studies of the DMP1 57-kDa functional domain both in vivo and in vitro. Cells Tissues Organs 2009, 189:175-185.
148. Lorenz-Depiereux B., Bastepe M., Benet-Pages A., et al. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 2006, 38:1248-1250.
149. Terkeltaub R. Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcification. Purinergic Signal 2006, 2:371-377.
150. Rutsch F., Vaingankar S., Johnson K., et al. PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 2001, 158:543-554.
151. Rutsch F., Ruf N., Vaingankar S., et al. Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat Genet 2003, 34:379-381.
152. Levy-Litan V., Hershkovitz E., Avizov L., et al. Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet 2010, 86:273-278.
153. Lorenz-Depiereux B., Schnabel D., Tiosano D., Hausler G., Strom T.M. Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet 2010, 86:267-272.
154. Chodirker B.N., Evans J.A., Seargeant L.E., Cheang M.S., Greenberg C.R. Hyperphosphatemia in infantile hypophosphatasia: implications for carrier diagnosis and screening. Am J Hum Genet 1990, 46:280-285.
155. Burnett S.M., Gunawardene S.C., Bringhurst F.R., Jüppner H., Lee H., Finkelstein J.S. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 2006, 21:1187-1196.
156. Nishi H., Nii-Kono T., Nakanishi S., et al. Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism. Nephron Clin Pract 2005, 101:c94-c99.
157. Kolek O.I., Hines E.R., Jones M.D., et al. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol 2005, 289:G1036-G1042.
158. Shimada T., Hasegawa H., Yamazaki Y., et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004, 19:429-435.
159. Yu X., Sabbagh Y., Davis S.I., Demay M.B., White K.E. Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations. Bone 2005, 36:971-977.
160. Chefetz I., Kohno K., Izumi H., Uitto J., Richard G., Sprecher E. GALNT3, a gene associated with hyperphosphatemic familial tumoral calcinosis, is transcriptionally regulated by extracellular phosphate and modulates matrix metalloproteinase activity. Biochim Biophys Acta 2009, 1792:61-67.
161. Bhattacharyya N, Andreopoulou P, Dumitrescu C, Miwa H, Gafni R, Collins M. Cyclic AMP-mediated processing of FGF23: regulation by O-glycosylation. J Bone Miner Res. In press. Abstract A09003028.
162. Frishberg Y., Ito N., Rinat C., et al. Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23. J Bone Miner Res 2007, 22:235-242.
163. Bergwitz C., Banerjee S., Abu-Zahra H., et al. Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis. J Clin Endocrinol Metab 2009, 94:4267-4274.
164. Larsson T., Davis S.I., Garringer H.J., et al. Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed. Endocrinology 2005, 146:3883-3891.
165. Ichikawa S., Sorenson A.H., Austin A.M., et al. Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression. Endocrinology 2009, 150:2543-2550.
166. Riminucci M., Collins M.T., Fedarko N.S., et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 2003, 112:683-692.